C07D 207/12
Oxygen or sulfur atoms
C07D207/12 (Oxygen or sulfur atoms) appears on 1,020 US grants and 1,033 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,020
- Published applications
- 1,033
- Assignees
- 525
- Inventors
- 3,228
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 9 | 0 |
| 1977 | 4 | 0 |
| 1978 | 4 | 0 |
| 1979 | 8 | 0 |
| 1980 | 5 | 0 |
| 1981 | 4 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 5 | 0 |
| 1985 | 5 | 0 |
| 1986 | 7 | 0 |
| 1987 | 10 | 0 |
| 1988 | 4 | 0 |
| 1989 | 10 | 0 |
| 1990 | 12 | 0 |
| 1991 | 13 | 0 |
| 1992 | 8 | 0 |
| 1993 | 9 | 0 |
| 1994 | 10 | 0 |
| 1995 | 19 | 0 |
| 1996 | 18 | 0 |
| 1997 | 16 | 0 |
| 1998 | 15 | 0 |
| 1999 | 15 | 0 |
| 2000 | 19 | 0 |
| 2001 | 34 | 9 |
| 2002 | 37 | 30 |
| 2003 | 19 | 37 |
| 2004 | 20 | 58 |
| 2005 | 23 | 44 |
| 2006 | 31 | 46 |
| 2007 | 28 | 62 |
| 2008 | 31 | 37 |
| 2009 | 34 | 60 |
| 2010 | 43 | 42 |
| 2011 | 37 | 45 |
| 2012 | 31 | 40 |
| 2013 | 38 | 42 |
| 2014 | 35 | 46 |
| 2015 | 46 | 50 |
| 2016 | 26 | 34 |
| 2017 | 37 | 30 |
| 2018 | 29 | 38 |
| 2019 | 32 | 33 |
| 2020 | 30 | 42 |
| 2021 | 32 | 44 |
| 2022 | 28 | 37 |
| 2023 | 22 | 37 |
| 2024 | 23 | 36 |
| 2025 | 19 | 35 |
| 2026 | 22 | 19 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- P38alpha mitogen-activated protein kinase inhibitors6 Oct 2026US 12,753,184 B2Gen1E Lifesciences Inc.
- Bioactive phytochemicals in Zizyphus and guarana29 Sep 2026US 12,747,206 B2Phytoquest Limited
- Inhibitors of spinster homolog 2 (SPNS2) for use in therapy22 Sep 2026US 12,741,944 B2University of Virginia Patent Foundation
- Coronavirus main protease inhibitors and methods using same8 Sep 2026US 12,729,190 B2Baylor College of Medicine
- Crystalline form of sofpironium bromide and preparation method thereof11 Aug 2026US 12,703,682 B2Brickell Biotech, Inc.
- Glycopyrrolate salts24 Sep 2026US 2026/0284007 A1Journey Medical Corporation
- New Process for the Preparation of Fluoropyrrolidine27 Aug 2026US 2026/0250244 A1Hoffmann-La Roche Inc.
- EP2 Antagonist Compounds13 Aug 2026US 2026/0234130 A1Reservoir Neuroscience, Inc.
- Processes for producing reaction products including quaternary ammonium salts13 Aug 2026US 2026/0234299 A1The Lubrizol Corporation
- Compounds and compositions for intracellular delivery of nucleic acid-based therapeutics and methods thereof30 Jul 2026US 2026/0216070 A1NanoTech Pharma Inc.
Most cited
By later US patents
- Pyrrolidine-containing monomers and oligomers675US 5,519,134 AIsis Pharmaceuticals, Inc. · 1996
- Trifunctional intermediates for preparing 3'-tailed oligonucleotides292US 5,512,667 A1996
- Arylsulfonylamino hydroxamic acid derivatives213US 5,863,949 APfizer Inc. · 1999
- Sigma receptor ligands and the use thereof150US 6,057,371 AVirginia Commonwealth University · 2000
- 2-Aminocycloaliphatic amide compounds92US 4,145,435 AThe Upjohn Company · 1979